CCR4 contributes to the pathogenesis of experimental autoimmune encephalomyelitis by regulating inflammatory macrophage function

Journal of Neuroimmunology

Volumn 236, Issue 1-2, 2011, Pages 17-26

  Forde, Eileen A ^a   Dogan, Rukiye Nazan E ^a   Karpus, William J ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

CCR4; Central nervous system; Chemokine receptor; Experimental autoimmune encephalomyelitis; Inflammatory macrophage; Multiple sclerosis

Indexed keywords

CD11B ANTIGEN; CHEMOKINE RECEPTOR CCR4;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELLULAR IMMUNITY; CONTROLLED STUDY; FEMALE; IMMUNOREGULATION; INFLAMMATORY MACROPHAGE; MACROPHAGE; MACROPHAGE FUNCTION; MOUSE; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; RISK FACTOR; T LYMPHOCYTE;

AMINO ACID SEQUENCE; ANIMALS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; INFLAMMATION MEDIATORS; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; RECEPTORS, CCR4;

EID: 79960195666     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2011.04.008     Document Type: Article

References (75)

1. Abdul-Majid K.B., Wefer J., Stadelmann C., Stefferl A., Lassmann H., Olsson T., Harris R.A. Comparing the pathogenesis of experimental autoimmune encephalomyelitis in CD4Z-/- and CD8Z-/- DBA/1 mice defines qualitative roles of different T cell subsets. J. Neuroimmunol. 2003, 141:10-19.
2. Abi-Younes S., Si-Tahar M., Luster A.D. The CC chemokines MDC and TARC induce platelet activation via CCR4. Thromb. Res. 2001, 101:279-289.
3. Abromson-Leeman S., Ladell D.S., Bronson R.T., Dorf M.E. Heterogeneity of EAE mediated by multiple distinct T-effector subsets. J. Neuroimmunol. 2007, 192:3-12.
4. Andrew D.P., Chang M.S., McNinch J., Wathen S.T., Rihanek M., Tseng J., Spellberg J.P., Elias C.G. STCP-1 (MDC) CC chemokine acts specifically on chronically activated Th2 lymphocytes and is produced by monocytes on stimulation with Th2 cytokines IL-4 and IL-13. J. Immunol. 1998, 161:5027-5038.
5. + T(H)-17 cells in relapsing EAE. Nat. Immunol. 2007, 8:172-180.
6. Baron J.L., Madri J.A., Ruddle N.H., Hashim G., Janeway C.A. Surface expression of alpha 4 integrin by CD4 T cells is required for their entry into brain parenchyma. J. Exp. Med. 1993, 177:57-68.
7. Bettelli E., Das M.P., Howard E.D., Weiner H.L., Sobel R.A., Kuchroo V.K. IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice. J. Immunol. 1998, 161:3299-3306.
8. Bettelli E., Pagany M., Weiner H.L., Linington C., Sobel R.A., Kuchroo V.K. Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis. J. Exp. Med. 2003, 197:1073-1081.
9. Bettelli E., Korn T., Oukka M., Kuchroo V.K. Induction and effector functions of TH17 cells. Nature 2008, 453:1051-1057.
10. Brosnan C.F., Bornstein M.B., Bloom B.R. The effects of macrophage depletion on the clinical and pathologic expression of experimental allergic encephalomyelitis. J. Immunol. 1981, 126:614-620.
11. Bruck W., Porada P., Poser S., Rieckmann P., Hanefeld F., Kretzschmar H.A., Lassmann H. Monocyte/macrophage differentiation in early multiple sclerosis lesions. Ann. Neurol. 1995, 38:788-796.
12. Burdi D.F., Chi S., Mattia K., Harrington C., Shi Z., Chen S., Jacutin-Porte S., Bennett R., Carson K., Yin W., Kansra V., Gonzalo J.A., Coyle A., Jaffee B., Ocain T., Hodge M., LaRosa G., Harriman G. Small molecule antagonists of the CC chemokine receptor 4 (CCR4). Bioorg. Med. Chem. Lett. 2007, 17:3141-3145.
13. Carlson T., Kroenke M., Rao P., Lane T.E., Segal B. The Th17-ELR+CXC chemokine pathway is essential for the development of central nervous system autoimmune disease. J. Exp. Med. 2008, 205:811-823.
14. Carter L.L., Leach M.W., Azoitei M.L., Cui J., Pelker J.W., Jussif J., Benoit S., Ireland G., Luxenberg D., Askew G.R., Milarski K.L., Groves C., Brown T., Carito B.A., Percival K., Carreno B.M., Collins M., Marusic S. PD-1/PD-L1, but not PD-1/PD-L2, interactions regulate the severity of experimental autoimmune encephalomyelitis. J. Neuroimmunol. 2007, 182:124-134.
15. Chvatchko Y., Hoogewerf A.J., Meyer A., Alouani S., Juillard P., Buser R., Conquet F., Proudfoot A.E., Wells T.N., Power C.A. A key role for CC chemokine receptor 4 in lipopolysaccharide-induced endotoxic shock. J. Exp. Med. 2000, 191:1755-1764.
16. Columba-Cabezas S., Serafini B., Ambrosini E., Sanchez M., Penna G., Adorini L., Aloisi F. Induction of macrophage-derived chemokine/CCL22 expression in experimental autoimmune encephalomyelitis and cultured microglia: implications for disease regulation. J. Neuroimmunol. 2002, 130:10-21.
17. Dardalhon V., Korn T., Kuchroo V.K., Anderson A.C. Role of Th1 and Th17 cells in organ-specific autoimmunity. J. Autoimmun. 2008, 31:252-256.
18. Dogan R.N., Long N., Forde E., Dennis K., Kohm A.P., Miller S.D., Karpus W.J. CCL22 regulates experimental autoimmune encephalomyelitis by controlling inflammatory macrophage accumulation and effector function. J. Leukoc. Biol. 2011, 89:93-104.
19. Elhofy A., Depaolo R.W., Lira S.A., Lukacs N.W., Karpus W.J. Mice deficient for CCR6 fail to control chronic experimental autoimmune encephalomyelitis. J. Neuroimmunol. 2009, 213:91-99.
20. Engelhardt B. Immune cell entry into the central nervous system: involvement of adhesion molecules and chemokines. J. Neurol. Sci. 2008, 15:23-26.
21. Fife B.T., Huffnagle G.B., Kuziel W.A., Karpus W.J. CC chemokine receptor 2 is critical for induction of experimental autoimmune encephalomyelitis. J. Exp. Med. 2000, 192:899-905.
22. Fife B.T., Kennedy K.J., Paniagua M.C., Lukacs N.W., Kunkel S.L., Luster A.D., Karpus W.J. CXCL10 (IFN-gamma-inducible protein-10) control of encephalitogenic CD4+ T cell accumulation in the central nervous system during experimental autoimmune encephalomyelitis. J. Immunol. 2001, 166:7617-7624.
23. Forster R., Davalos-Misslitz A.C., Rot A. CCR7 and its ligands: balancing immunity and tolerance. Nat. Rev. Immunol. 2008, 8:362-371.
24. Galimberti D., Fenoglio C., Comi C., Scalabrini D., De Riz M., Leone M., Venturelli E., Cortini F., Piola M., Monaco F., Bresolin N., Scarpini E. MDC/CCL22 intrathecal levels in patients with multiple sclerosis. Mult. Scler. 2008, 14:547-549.
25. Galimberti D., Scalabrini D., Fenoglio C., De Riz M., Comi C., Venturelli E., Cortini F., Piola M., Leone M., Dianzani U., D'Alfonso S., Monaco F., Bresolin N., Scarpini E. Gender-specific influence of the chromosome 16 chemokine gene cluster on the susceptibility to multiple sclerosis. J. Neurol. Sci. 2008, 267:86-90.
26. Garcia G.E., Xia Y., Harrison J., Wilson C.B., Johnson R.J., Bacon K.B., Feng L. Mononuclear cell-infiltrate inhibition by blocking macrophage-derived chemokine results in attenuation of developing crescentic glomerulonephritis. Am. J. Pathol. 2003, 162:1061-1073.
27. Geissmann F., Jung S., Littman D.R. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 2003, 19:71-82.
28. Gordon S., Taylor P.R. Monocyte and macrophage heterogeneity. Nat. Rev. Immunol. 2005, 5:953-964.
29. Gu L., Tseng S., Horner R.M., Tam C., Loda M., Rollins B.J. Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1. Nature 2000, 404:407-411.
30. Hatakeyama S., Iwabuchi K., Ogasawara K., Good R.A., Onoe K. The murine c-fgr gene product associated with Ly6C and p70 integral membrane protein is expressed in cells of a monocyte/macrophage lineage. Proc. Natl. Acad. Sci. U. S. A 1994, 91:3458-3462.
31. Hickey W.F. The pathology of multiple sclerosis: a historical perspective. J. Neuroimmunol. 1999, 98:37-44.
32. Hickey W.F., Gonatas N.K., Kimura H., Wilson D.B. Identification and quantitation of T lymphocyte subsets found in the spinal cord of the Lewis rat during acute experimental allergic encephalomyelitis. J. Immunol. 1983, 131:2805-2809.
33. Huang D.R., Wang J., Kivisakk P., Rollins B.J., Ransohoff R.M. Absence of monocyte chemoattractant protein 1 in mice leads to decreased local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitis. J. Exp. Med. 2001, 193:713-726.
34. Huitinga I., Damoiseaux J.G., Dopp E.A., Dijkstra C.D. Treatment with anti-CR3 antibodies ED7 and ED8 suppresses experimental allergic encephalomyelitis in Lewis rats. Eur. J. Immunol. 1993, 23:709-715.
35. Huitinga I., Ruuls S.R., Jung S., Van Rooijen N., Hartung H.P., Dijkstra C.D. Macrophages in T cell line-mediated, demyelinating, and chronic relapsing experimental autoimmune encephalomyelitis in Lewis rats. Clin. Exp. Immunol. 1995, 100:344-351.
36. Imai T., Yoshida T., Baba M., Nishimura M., Kakizaki M., Yoshie O. Molecular cloning of a novel T cell-directed CC chemokine expressed in thymus by signal sequence trap using Epstein-Barr virus vector. J. Biol. Chem. 1996, 271:21514-21521.
37. Imai T., Nagira M., Takagi S., Kakizaki M., Nishimura M., Wang J., Gray P.W., Matsushima K., Yoshie O. Selective recruitment of CCR4-bearing Th2 cells toward antigen-presenting cells by the CC chemokines thymus and activation-regulated chemokine and macrophage-derived chemokine. Int. Immunol. 1999, 11:81-88.
38. Ishii M., Hogaboam C.M., Joshi A., Ito T., Fong D.J., Kunkel S.L. CC chemokine receptor 4 modulates Toll-like receptor 9-mediated innate immunity and signaling. Eur. J. Immunol. 2008, 38:2290-2302.
39. Jakubzick C., Wen H., Matsukawa A., Keller M., Kunkel S.L., Hogaboam C.M. Role of CCR4 ligands, CCL17 and CCL22, during Schistosoma mansoni egg-induced pulmonary granuloma formation in mice. Am. J. Pathol. 2004, 165:1211-1221.
40. Jensen M.A., Arnason B.G., Toscas A., Noronha A. Preferential increase of IL-2R+CD4+ T cells and CD45RB-CD4+ T cells in the central nervous system in experimental allergic encephalomyelitis. J. Neuroimmunol. 1992, 38:255-261.
41. Karpus W.J., Kennedy K.J. MIP-1alpha and MCP-1 differentially regulate acute and relapsing autoimmune encephalomyelitis as well as Th1/Th2 lymphocyte differentiation. J. Leukoc. Biol. 1997, 62:681-687.
42. Karpus W.J., Lukacs N.W., McRae B.L., Strieter R.M., Kunkel S.L., Miller S.D. An important role for the chemokine macrophage inflammatory protein-1 alpha in the pathogenesis of the T cell-mediated autoimmune disease, experimental autoimmune encephalomyelitis. J. Immunol. 1995, 155:5003-5010.
43. Karpus W.J., Lukacs N.W., Kennedy K.J., Smith W.S., Hurst S.D., Barrett T.A. Differential CC chemokine-induced enhancement of T helper cell cytokine production. J. Immunol. 1997, 158:4129-4136.
44. King I.L., Dickendesher T.L., Segal B.M. Circulating Ly-6C+ myeloid precursors migrate to the CNS and play a pathogenic role during autoimmune demyelinating disease. Blood 2009, 113:3190-3197.
45. Kuchroo V.K., Martin C.A., Greer J.M., Ju S.T., Sobel R.A., Dorf M.E. Cytokines and adhesion molecules contribute to the ability of myelin proteolipid protein-specific T cell clones to mediate experimental allergic encephalomyelitis. J. Immunol. 1993, 151:4371-4382.
46. Lee I., Wang L., Wells A.D., Dorf M.E., Ozkaynak E., Hancock W.W. Recruitment of Foxp3+ T regulatory cells mediating allograft tolerance depends on the CCR4 chemokine receptor. J. Exp. Med. 2005, 201:1037-1044.
47. Liang S.C., Latchman Y.E., Buhlmann J.E., Tomczak M.F., Horwitz B.H., Freeman G.J., Sharpe A.H. Regulation of PD-1, PD-L1, and PD-L2 expression during normal and autoimmune responses. Eur. J. Immunol. 2003, 33:2706-2716.
48. Mantovani A., Sica A., Sozzani S., Allavena P., Vecchi A., Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 2004, 25:677-686.
49. Marsland B.J., Battig P., Bauer M., Ruedl C., Lassing U., Beerli R.R., Dietmeier K., Ivanova L., Pfister T., Vogt L., Nakano H., Nembrini C., Saudan P., Kopf M., Bachmann M.F. CCL19 and CCL21 induce a potent proinflammatory differentiation program in licensed dendritic cells. Immunity 2005, 22:493-505.
50. Matsukawa A., Hogaboam C.M., Lukacs N.W., Lincoln P.M., Evanoff H.L., Kunkel S.L. Pivotal role of the CC chemokine, macrophage-derived chemokine, in the innate immune response. J. Immunol. 2000, 164:5362-5368.
51. McDonald J.R. Selective chemokine receptor-targeted depletion of pathological cells as a therapeutic strategy for inflammatory, allergic and autoimmune diseases. Recent Pat. Inflamm. Allergy Drug Discov. 2009, 3:177-187.
52. Meyer E.H., Wurbel M.A., Staton T.L., Pichavant M., Kan M.J., Savage P.B., DeKruyff R.H., Butcher E.C., Campbell J.J., Umetsu D.T. iNKT cells require CCR4 to localize to the airways and to induce airway hyperreactivity. J. Immunol. 2007, 179:4661-4671.
53. Mikita J., Dubourdieu-Cassagno N., Deloire M.S., Vekris A., Biran M., Raffard G., Brochet B., Canron M.H., Franconi J.M., Boiziau C., Petry K.G. Altered M1/M2 activation patterns of monocytes in severe relapsing experimental rat model of multiple sclerosis. Amelioration of clinical status by M2 activated monocyte administration. Mult. Scler. 2011, 17:2-15.
54. Miller S.D., Karpus W.J., Davidson T.S. Experimental autoimmune encephalomyelitis in the mouse. Curr. Protoc. Immunol. 2010, Chapter 15. Unit 15 11.
55. Ness T.L., Ewing J.L., Hogaboam C.M., Kunkel S.L. CCR4 is a key modulator of innate immune responses. J. Immunol. 2006, 177:7531-7539.
56. Ness T.L., Ewing J.L., Hogaboam C.M., Kunkel S.L. CCR4 is a key modulator of innate immune responses. J. Immunol. 2006, 177:7531-7539.
57. Pope J.G., Karpus W.J., VanderLugt C., Miller S.D. Flow cytometric and functional analyses of central nervous system-infiltrating cells in SJL/J mice with Theiler's virus-induced demyelinating disease. Evidence for a CD4+ T cell-mediated pathology. J. Immunol. 1996, 156:4050-4058.
58. Rott O., Fleischer B., Cash E. Interleukin-10 prevents experimental allergic encephalomyelitis in rats. Eur. J. Immunol. 1994, 24:1434-1440.
59. Rottman J.B., Slavin A.J., Silva R., Weiner H.L., Gerard C.G., Hancock W.W. Leukocyte recruitment during onset of experimental allergic encephalomyelitis is CCR1 dependent. Eur. J. Immunol. 2000, 30:2372-2377.
60. Schreiner B., Bailey S.L., Shin T., Chen L., Miller S.D. PD-1 ligands expressed on myeloid-derived APC in the CNS regulate T-cell responses in EAE. Eur. J. Immunol. 2008, 38:2706-2717.
61. Segal B.M., Dwyer B.K., Shevach E.M. An interleukin (IL)-10/IL-12 immunoregulatory circuit controls susceptibility to autoimmune disease. J. Exp. Med. 1998, 187:537-546.
62. Serbina N.V., Salazar-Mather T.P., Biron C.A., Kuziel W.A., Pamer E.G. TNF/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection. Immunity 2003, 19:59-70.
63. Slavin A., Ewing C., Liu J., Ichikawa M., Slavin J., Bernard C.C. Induction of a multiple sclerosis-like disease in mice with an immunodominant epitope of myelin oligodendrocyte glycoprotein. Autoimmunity 1998, 28:109-120.
64. Stephens L.A., Gray D., Anderton S.M. CD4+CD25+ regulatory T cells limit the risk of autoimmune disease arising from T cell receptor crossreactivity. Proc. Natl. Acad. Sci. U. S. A 2005, 102:17418-17423.
65. Stolberg V.R., Chiu B.C., Schmidt B.M., Kunkel S.L., Sandor M., Chensue S.W. CC chemokine receptor 4 contributes to innate NK and chronic stage T helper cell recall responses during mycobacterium bovis infection. Am. J. Pathol. 2011, 178:233-244.
66. Tierney J.B., Kharkrang M., La Flamme A.C. Type II-activated macrophages suppress the development of experimental autoimmune encephalomyelitis. Immunol. Cell Biol. 2009, 87:235-240.
67. Trujillo G., O'Connor E.C., Kunkel S.L., Hogaboam C.M. A novel mechanism for CCR4 in the regulation of macrophage activation in bleomycin-induced pulmonary fibrosis. Am. J. Pathol. 2008, 172:1209-1221.
68. Vestergaard C., Bang K., Gesser B., Yoneyama H., Matsushima K., Larsen C.G. A Th2 chemokine, TARC, produced by keratinocytes may recruit CLA+CCR4+ lymphocytes into lesional atopic dermatitis skin. J. Invest. Dermatol. 2000, 115:640-646.
69. Weber M.S., Prod'homme T., Youssef S., Dunn S.E., Rundle C.D., Lee L., Patarroyo J.C., Stuve O., Sobel R.A., Steinman L., Zamvil S.S. Type II monocytes modulate T cell-mediated central nervous system autoimmune disease. Nat. Med. 2007, 13:935-943.
70. Whitham R.H., Bourdette D.N., Hashim G.A., Herndon R.M., Ilg R.C., Vandenbark A.A., Offner H. Lymphocytes from SJL/J mice immunized with spinal cord respond selectively to a peptide of proteolipid protein and transfer relapsing demyelinating experimental autoimmune encephalomyelitis. J. Immunol. 1991, 146:101-107.
71. Yang Z.Z., Novak A.J., Stenson M.J., Witzig T.E., Ansell S.M. Intratumoral CD4+CD25+ regulatory T-cell-mediated suppression of infiltrating CD4+ T cells in B-cell non-Hodgkin lymphoma. Blood 2006, 107:3639-3646.
72. Yogo Y., Fujishima S., Inoue T., Saito F., Shiomi T., Yamaguchi K., Ishizaka A. Macrophage derived chemokine (CCL22), thymus and activation-regulated chemokine (CCL17), and CCR4 in idiopathic pulmonary fibrosis. Respir. Res. 2009, 10:80.
73. Yu P., Gregg R.K., Bell J.J., Ellis J.S., Divekar R., Lee H.H., Jain R., Waldner H., Hardaway J.C., Collins M., Kuchroo V.K., Zaghouani H. Specific T regulatory cells display broad suppressive functions against experimental allergic encephalomyelitis upon activation with cognate antigen. J. Immunol. 2005, 174:6772-6780.
74. Zhang X., Koldzic D.N., Izikson L., Reddy J., Nazareno R.F., Sakaguchi S., Kuchroo V.K., Weiner H.L. IL-10 is involved in the suppression of experimental autoimmune encephalomyelitis by CD25+CD4+ regulatory T cells. Int. Immunol. 2004, 16:249-256.
75. Zhu B., Guleria I., Khosroshahi A., Chitnis T., Imitola J., Azuma M., Yagita H., Sayegh M.H., Khoury S.J. Differential role of programmed death-1 ligand and programmed death-2 ligand in regulating the susceptibility and chronic progression of experimental autoimmune encephalomyelitis. J. Immunol. 2006, 176:3480-3489.